Specifically, the FDA states that microdosing is not a regulated term and there is no clinical evidence from large-scale trials demonstrating the safety and effectiveness of GLP-1 microdosing for mild appetite control, weight management, or longevity
Yes, nausea is one of the most commonly reported side effects of retatrutide
Super friendly staff
An alternative, Wegovy (semaglutide), may be covered when used for heart disease indications
HSA and FSA reimbursement is sometimes possible when medication is prescribed for diagnosed obesity (BMI 30+) or type 2 diabetes
In this blog, we'll explore how glutathione connects both conditions at the cellular level, why other approaches often fall short, and how supporting your cellular foundation can restore your body's natural resilience to environmental challenges